MedPath

EXcorLab GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:1
Completed:3

Trial Phases

2 Phases

Phase 4:1
Not Applicable:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (80.0%)
Phase 4
1 (20.0%)

Sodium Chloride and Protein-Bound Toxin Removal in Hemodiafiltration

Not Applicable
Completed
Conditions
End-stage Renal Disease
First Posted Date
2013-08-16
Last Posted Date
2019-01-16
Lead Sponsor
EXcorLab GmbH
Target Recruit Count
8
Registration Number
NCT01923961
Locations
🇩🇪

Dialysis Center Elsenfeld, Elsenfeld, Bavaria, Germany

Test of the Nipro ELISIO H Dialyzer in Different Dialysis Treatment Procedures

Not Applicable
Completed
Conditions
Chronic Kidney Disease
First Posted Date
2008-08-14
Last Posted Date
2009-08-21
Lead Sponsor
EXcorLab GmbH
Target Recruit Count
14
Registration Number
NCT00735059
Locations
🇧🇪

University Hospital, Ghent, Belgium

Granulocytapheresis in Psoriasis

Not Applicable
Terminated
Conditions
Psoriasis
First Posted Date
2008-07-14
Last Posted Date
2020-08-14
Lead Sponsor
EXcorLab GmbH
Target Recruit Count
4
Registration Number
NCT00714272
Locations
🇩🇪

University of Würzburg, Department of Medicine, Division of Nephrology, and Department of Dermatology, Wuerzburg, Bavaria, Germany

🇩🇪

University of Göttingen, Department of Dermatology and Department of Nephrology and Rheumatology, Göttingen, Lower Saxony, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.